Transport
Memorial Hermann Health System
Memorial Hermann Health System was paid $39.46M by Medicaid between Feb 2018 and Dec 2024, across 171 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoMEMORIAL HERMANN HEALTH SYSTEM
HOUSTON, TX 77030
HOUSTON, TX 77030
33aNPI1982666111assigned 04/04/2006
33bProvider typeAir Ambulance
28Total paid$39.46M
24GClaims206,956
24DCodes billed171
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Air Ambulance providers in Texas
Rank by total paid#1 of 17
Median peer was paid$429K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 204 | $272K | |
| 2019 | 395 | $346K | |
| 2020 | 4,462 | $1.21M | |
| 2021 | 52,928 | $9.41M | |
| 2022 | 55,706 | $10.20M | |
| 2023 | 56,512 | $12.20M | |
| 2024incomplete | 36,749 | $5.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 20,099 | 19,230 | $11.87M |
| A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | 27% | 2,935 | 2,766 | $10.58M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.6% | 18,444 | 17,926 | $2.99M |
| A0436 | Rotary wing air mileage, per statute mile | 7.5% | 2,929 | 2,764 | $2.98M |
| 95716 | 5.4% | 1,057 | 1,015 | $2.12M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.1% | 4,624 | 4,324 | $2.00M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 2.5% | 318 | 312 | $982K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 2.0% | 529 | 522 | $784K |
| 95700 | 1.4% | 1,099 | 1,065 | $536K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,330 | 17,750 | $383K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,351 | 4,815 | $344K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 238 | 231 | $314K |
159 more codes
| 80053 | Comprehensive metabolic panel | <1% | 8,470 | $309K |
| 95782 | <1% | 156 | $213K | |
| A0434 | Specialty care transport (sct) | <1% | 203 | $210K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 246 | $195K |
| A0425 | Ground mileage, per statute mile | <1% | 1,506 | $188K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,086 | $164K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 99 | $152K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 936 | $150K |
| 81001 | <1% | 8,270 | $132K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,938 | $131K |
| A0422 | Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation | <1% | 2,726 | $116K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 507 | $112K |
| 76770 | <1% | 472 | $111K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,609 | $109K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,656 | $81K |
| 86850 | <1% | 2,879 | $69K | |
| J3490 | Unclassified drugs | <1% | 2,626 | $63K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,537 | $59K |
| 87400 | <1% | 1,508 | $56K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 136 | $54K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 457 | $48K |
| A0398 | Als routine disposable supplies | <1% | 732 | $44K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 781 | $40K |
| 36512 | <1% | 13 | $36K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 85 | $33K |
| 93975 | <1% | 178 | $33K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,730 | $32K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,147 | $30K |
| 80076 | <1% | 2,314 | $30K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 791 | $25K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 273 | $24K |
| 76801 | <1% | 249 | $22K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,482 | $21K |
| 82977 | <1% | 534 | $21K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 48 | $20K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 485 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,213 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 498 | $16K |
| 84484 | <1% | 2,540 | $16K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 66 | $15K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,520 | $14K |
| 85610 | <1% | 4,047 | $14K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 46 | $12K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 706 | $11K |
| 86900 | <1% | 2,949 | $11K | |
| 82570 | <1% | 471 | $11K | |
| 86901 | <1% | 2,947 | $11K | |
| 83735 | <1% | 3,114 | $11K | |
| 82803 | <1% | 916 | $9K | |
| 81025 | <1% | 1,214 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,347 | $9K |
| 83690 | <1% | 1,521 | $9K | |
| 84702 | <1% | 719 | $9K | |
| 83880 | <1% | 633 | $8K | |
| 80197 | <1% | 402 | $8K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,523 | $8K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 268 | $8K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 677 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 785 | $7K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,348 | $7K |
| 85730 | <1% | 2,311 | $7K | |
| 83605 | <1% | 1,435 | $7K | |
| 96376 | <1% | 428 | $6K | |
| 83020 | <1% | 135 | $6K | |
| 82077 | <1% | 661 | $5K | |
| 84156 | <1% | 405 | $5K | |
| 84703 | <1% | 578 | $5K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 37 | $5K |
| 84100 | <1% | 2,382 | $5K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 66 | $5K |
| 97162 | <1% | 101 | $4K | |
| 84450 | <1% | 388 | $4K | |
| 85576 | <1% | 412 | $4K | |
| 82728 | <1% | 263 | $4K | |
| 84075 | <1% | 396 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 53 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 68 | $3K |
| 87799 | <1% | 26 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 126 | $3K |
| 73562 | <1% | 127 | $3K | |
| 87807 | <1% | 93 | $3K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 67 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 763 | $3K |
| 82330 | <1% | 742 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 70 | $2K |
| 82247 | <1% | 397 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 37 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 28 | $2K |
| 85384 | <1% | 531 | $2K | |
| 85390 | <1% | 324 | $2K | |
| 87497 | <1% | 31 | $2K | |
| 84155 | <1% | 389 | $2K | |
| 86999 | <1% | 58 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,090 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 59 | $2K |
| 82375 | <1% | 35 | $2K | |
| 82550 | <1% | 493 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 13 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 55 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,366 | $1K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 49 | $1K |
| 83615 | <1% | 574 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 426 | $1K |
| 70498 | <1% | 14 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 75 | $1K |
| 85347 | <1% | 560 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 71 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 401 | $1K |
| 97166 | <1% | 13 | $998.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,135 | $983.70 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $978.62 |
| 73610 | <1% | 56 | $971.09 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,216 | $909.06 |
| 87186 | <1% | 251 | $896.54 | |
| 85660 | <1% | 27 | $850.20 | |
| 82947 | <1% | 1,082 | $828.30 | |
| 86703 | <1% | 17 | $806.01 | |
| 70360 | <1% | 14 | $723.60 | |
| 86769 | <1% | 16 | $699.27 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 364 | $685.92 |
| 87340 | <1% | 41 | $670.06 | |
| 82043 | <1% | 106 | $653.19 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,647 | $651.16 |
| 82040 | <1% | 372 | $643.44 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 710 | $629.42 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,524 | $608.16 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 26 | $540.26 |
| 86780 | <1% | 31 | $536.60 | |
| 80061 | Lipid panel | <1% | 117 | $503.33 |
| 71250 | <1% | 14 | $480.51 | |
| 73130 | <1% | 27 | $476.96 | |
| 83970 | <1% | 14 | $462.75 | |
| 80179 | <1% | 49 | $427.40 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 328 | $421.22 |
| 73630 | <1% | 27 | $417.73 | |
| 80143 | <1% | 49 | $410.96 | |
| 94760 | <1% | 18 | $350.53 | |
| 90715 | <1% | 12 | $325.60 | |
| 84145 | <1% | 36 | $304.96 | |
| 73030 | <1% | 13 | $297.82 | |
| 73502 | <1% | 15 | $286.24 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 723 | $267.42 |
| 87040 | <1% | 48 | $252.96 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 229 | $220.30 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 69 | $214.23 |
| 36000 | <1% | 14 | $208.46 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 209 | $190.37 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 77 | $182.51 |
| 86140 | <1% | 68 | $164.63 | |
| 82610 | <1% | 89 | $150.58 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 78 | $142.63 |
| 82248 | <1% | 72 | $80.13 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 155 | $56.63 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 65 | $50.39 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 13 | $35.58 |
| 85045 | <1% | 20 | $23.45 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 13 | $17.18 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,094 | $1.35 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLARAWAY, DENNIS (CHIEF FINANCIAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.